February 7, 2022
Geoffrey Lynn, co-founder Avedia, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk
Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, visits Rich Bendis to discuss his career from NIH, to CEO of Avidea, to…
February 7, 2022
How Johns Hopkins Inventors’ Vision for Early Cancer Detection Got a $2.1B Boost – Johns Hopkins Technology Ventures
Johns Hopkins researchers Nickolas Papadopoulos, Ken Kinzler and Bert Vogelstein have spent their careers working on ways not just to…
February 7, 2022
2 technologies of which hospitals should be wary
Blockchain and "connected health" technology are two trends hospitals should not rush to adopt, according to two hospital innovation executives.…
February 7, 2022
Arcellx Announces Pricing of Initial Public Offering – Arcellx
GAITHERSBURG, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the…
February 7, 2022
Baltimore Fishbowl | University of Maryland, Baltimore County reaches nation’s highest level as research university –
The University of Maryland, Baltimore County has received a Carnegie Classification, the nation’s highest designation for research universities. Two other…
February 7, 2022
Amalgam named Best SaaS-Enabled Digital Health Platform!
Global Health & Pharma recently presented their seventh annual Biotechnology Awards and named Amalgam the Best SaaS-Enabled Digital Health Platform.…
February 7, 2022
American Gene Technologies’ HIV Clinical Trial Shows Blood Markers of Efficacy in Two More Patients
ROCKVILLE, MD. (PRWEB) FEBRUARY 02, 2022 Data from a Total of Five Patients Demonstrates Critical Markers of the Company's HIV…
